Hepatitis C Virus entry: The early steps in the viral replication cycle

Virology Journal

Volumn 6, Issue , 2009, Pages

  Sabahi, Ali ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD81 ANTIGEN; CLAUDIN 1; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OCCLUDIN; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN; SCAVENGER RECEPTOR B; VIRUS ENVELOPE PROTEIN;

CELL CULTURE; DRUG EFFICACY; GENOMICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; MONOTHERAPY; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; TREATMENT DURATION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS IDENTIFICATION; VIRUS PARTICLE; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 69049120305     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-117     Document Type: Review

References (125)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. MJ Alter D Kruszon-Moran OV Nainan GM McQuillan F Gao LA Moyer RA Kaslow HS Margolis, N Engl J Med 1999 341 556 562 10451460 10.1056/ NEJM199908193410802
2. Natural history of chronic hepatitis C. LB Seeff, Hepatology 2002 36 S35 46 12407575 10.1002/hep.1840360706
3. Viral hepatitis and liver cancer: the case of hepatitis C. M Levrero, Oncogene 2006 25 3834 3847 16799625 10.1038/sj.onc.1209562
4. Optimal therapy of hepatitis C. AM Di Bisceglie JH Hoofnagle, Hepatology 2002 36 S121 7 12407585 10.1002/hep.1840360716
5. Peginterferon and ribavirin for chronic hepatitis C. JH Hoofnagle LB Seeff, N Engl J Med 2006 355 2444 2451 17151366 10.1056/NEJMct061675
6. Hepatitis C and liver transplantation. RS Brown, Nature 2005 436 973 978 16107838 10.1038/nature04083
7. Replication of hepatitis C virus. D Moradpour F Penin CM Rice, Nat Rev Microbiol 2007 5 453 463 17487147 10.1038/nrmicro1645
8. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. P Simmonds J Bukh C Combet G Deleage N Enomoto S Feinstone P Halfon G Inchauspe C Kuiken G Maertens M Mizokami DG Murphy H Okamoto JM Pawlotsky F Penin E Sablon T Shin-I LJ Stuyver HJ Thiel S Viazov AJ Weiner A Widell, Hepatology 2005 42 962 973 16149085 10.1002/hep.20819
9. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Korner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 110 113 10390360 10.1126/science.285.5424.110
10. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. J Bukh T Pietschmann V Lohmann N Krieger K Faulk RE Engle S Govindarajan M Shapiro M St Claire R Bartenschlager, Proc Natl Acad Sci USA 2002 99 14416 14421 12391335 10.1073/pnas.212532699
11. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. B Bartosch J Dubuisson FL Cosset, J Exp Med 2003 197 633 642 12615904 10.1084/jem.20021756
12. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. M Flint C Logvinoff CM Rice JA McKeating, J Virol 2004 78 6875 6882 15194763 10.1128/JVI.78.13.6875-6882.2004
13. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. T Kato T Date M Miyamoto A Furusaka K Tokushige M Mizokami T Wakita, Gastroenterology 2003 125 1808 1817 14724833 10.1053/j.gastro.2003.09.023
14. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao K Murthy A Habermann HG Krausslich M Mizokami R Bartenschlager TJ Liang, Nat Med 2005 11 791 796 15951748 10.1038/nm1268
15. Complete replication of hepatitis C virus in cell culture. BD Lindenbach MJ Evans AJ Syder B Wolk TL Tellinghuisen CC Liu T Maruyama RO Hynes DR Burton JA McKeating CM Rice, Science 2005 309 623 626 15947137 10.1126/science.1114016
16. Robust hepatitis C virus infection in vitro. J Zhong P Gastaminza G Cheng S Kapadia T Kato DR Burton SF Wieland SL Uprichard T Wakita FV Chisari, Proc Natl Acad Sci USA 2005 102 9294 9299 15939869 10.1073/pnas.0503596102
17. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. BD Lindenbach P Meuleman A Ploss T Vanwolleghem AJ Syder JA McKeating RE Lanford SM Feinstone ME Major G Leroux-Roels CM Rice, Proc Natl Acad Sci USA 2006 103 3805 3809 16484368 10.1073/pnas.0511218103
18. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. AU Neumann NP Lam H Dahari DR Gretch TE Wiley TJ Layden AS Perelson, Science 1998 282 103 107 9756471 10.1126/science.282.5386. 103
19. Hepatitis C virus entry depends on clathrin-mediated endocytosis. E Blanchard S Belouzard L Goueslain T Wakita J Dubuisson C Wychowski Y Rouille, J Virol 2006 80 6964 6972 16809302 10.1128/JVI.00024-06
20. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. H Barth C Schafer MI Adah F Zhang RJ Linhardt H Toyoda A Kinoshita-Toyoda T Toida TH Van Kuppevelt E Depla F Von Weizsacker HE Blum TF Baumert, J Biol Chem 2003 278 41003 41012 12867431 10.1074/jbc. M302267200
21. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. A Goffard N Callens B Bartosch C Wychowski FL Cosset C Montpellier J Dubuisson, J Virol 2005 79 8400 8409 15956584 10.1128/JVI.79.13. 8400-8409.2005
22. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. H Barth EK Schnober F Zhang RJ Linhardt E Depla B Boson FL Cosset AH Patel HE Blum TF Baumert, J Virol 2006 80 10579 10590 16928753 10.1128/JVI.00941-06
23. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. A Basu T Kanda A Beyene K Saito K Meyer R Ray, J Virol 2007 81 3933 3941 17287282 10.1128/JVI.02622-06
24. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. K Morikawa Z Zhao T Date M Miyamoto A Murayama D Akazawa J Tanabe S Sone T Wakita, J Med Virol 2007 79 714 723 17457918 10.1002/jmv.20842
25. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. M Monazahian I Bohme S Bonk A Koch C Scholz S Grethe R Thomssen, J Med Virol 1999 57 223 229 10022791 10.1002/(SICI)1096-9071(199903)57:3〈223:: AID-JMV2〉3.0.CO;2-4
26. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. S Molina V Castet C Fournier-Wirth L Pichard-Garcia R Avner D Harats J Roitelman R Barbaras P Graber P Ghersa M Smolarsky A Funaro F Malavasi D Larrey J Coste JM Fabre A Sa-Cunha P Maurel, J Hepatol 2007 46 411 419 17156886 10.1016/j.jhep.2006.09.024
27. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. JP Gardner RJ Durso RR Arrigale GP Donovan PJ Maddon T Dragic WC Olson, Proc Natl Acad Sci USA 2003 100 4498 4503 12676990 10.1073/pnas.0831128100
28. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. PY Lozach H Lortat-Jacob A de Lacroix de Lavalette I Staropoli S Foung A Amara C Houles F Fieschi O Schwartz JL Virelizier F Arenzana-Seisdedos R Altmeyer, J Biol Chem 2003 278 20358 20366 12609975 10.1074/jbc.M301284200
29. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. EG Cormier RJ Durso F Tsamis L Boussemart C Manix WC Olson JP Gardner T Dragic, Proc Natl Acad Sci USA 2004 101 14067 14072 15371595 10.1073/pnas.0405695101
30. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. D Akazawa T Date K Morikawa A Murayama M Miyamoto M Kaga H Barth TF Baumert J Dubuisson T Wakita, J Virol 2007 81 5036 5045 17329343 10.1128/JVI.01573-06
31. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. T Allander X Forns SU Emerson RH Purcell J Bukh, Virology 2000 277 358 367 11080483 10.1006/viro.2000.0617
32. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry. C Bertaux T Dragic, J Virol 2006 80 4940 4948 16641285 10.1128/JVI.80.10.4940-4948.2006
33. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. L Cocquerel CC Kuo J Dubuisson S Levy, J Virol 2003 77 10677 10683 12970454 10.1128/JVI.77.19.10677-10683.2003
34. CD81 is an entry coreceptor for hepatitis C virus. EG Cormier F Tsamis F Kajumo RJ Durso JP Gardner T Dragic, Proc Natl Acad Sci USA 2004 101 7270 7274 15123813 10.1073/pnas.0402253101
35. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. E Falkowska F Kajumo E Garcia J Reinus T Dragic, J Virol 2007 81 8072 8079 17507469 10.1128/JVI.00459-07
36. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. M Flint C Maidens LD Loomis-Price C Shotton J Dubuisson P Monk A Higginbottom S Levy JA McKeating, J Virol 1999 73 6235 6244 10400713
37. Diverse CD81 proteins support hepatitis C virus infection. M Flint T von Hahn J Zhang M Farquhar CT Jones P Balfe CM Rice JA McKeating, J Virol 2006 80 11331 11342 16943299 10.1128/JVI.00104-06
38. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. G Koutsoudakis E Herrmann S Kallis R Bartenschlager T Pietschmann, J Virol 2007 81 588 598 17079281 10.1128/JVI.01534-06
39. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression. B Kronenberger C Sarrazin WP Hofmann M von Wagner E Herrmann C Welsch R Elez B Ruster A Piiper S Zeuzem, J Viral Hepat 2004 11 310 318 15230853 10.1111/j.1365-2893.2004.00508.x
40. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. D Lavillette AW Tarr C Voisset P Donot B Bartosch C Bain AH Patel J Dubuisson JK Ball FL Cosset, Hepatology 2005 41 265 274 15660396 10.1002/hep.20542
41. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. JA McKeating LQ Zhang C Logvinoff M Flint J Zhang J Yu D Butera DD Ho LB Dustin CM Rice P Balfe, J Virol 2004 78 8496 8505 15280458 10.1128/JVI.78.16.8496-8505.2004
42. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. S Molina V Castet L Pichard-Garcia C Wychowski E Meurs JM Pascussi C Sureau JM Fabre A Sacunha D Larrey J Dubuisson J Coste J McKeating P Maurel C Fournier-Wirth, J Virol 2008 82 569 574 17942559 10.1128/JVI.01443-07
43. Binding of hepatitis C virus to CD81. P Pileri Y Uematsu S Campagnoli G Galli F Falugi R Petracca AJ Weiner M Houghton D Rosa G Grandi S Abrignani, Science 1998 282 938 941 9794763 10.1126/science.282.5390.938
44. In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines. M Sasaki K Yamauchi T Nakanishi Y Kamogawa N Hayashi, J Gastroenterol Hepatol 2003 18 74 79 12519228 10.1046/j.1440-1746.2003.02925.x
45. CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo. YJ Tan SP Lim P Ng PY Goh SG Lim YH Tan W Hong, Virology 2003 308 250 269 12706076 10.1016/S0042-6822(02)00136-8
46. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. C Voisset M Lavie F Helle A Op De Beeck A Bilheu J Bertrand-Michel F Terce L Cocquerel C Wychowski N Vu-Dac J Dubuisson, Cell Microbiol 2008 10 606 617 17979982 10.1111/j.1462-5822.2007.01070.x
47. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Zhang G Randall A Higginbottom P Monk CM Rice JA McKeating, J Virol 2004 78 1448 1455 14722300 10.1128/JVI.78.3.1448-1455.2004
48. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. E Scarselli H Ansuini R Cerino RM Roccasecca S Acali G Filocamo C Traboni A Nicosia R Cortese A Vitelli, EMBO J 2002 21 5017 5025 12356718 10.1093/emboj/cdf529
49. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. B Bartosch A Vitelli C Granier C Goujon J Dubuisson S Pascale E Scarselli R Cortese A Nicosia FL Cosset, J Biol Chem 2003 278 41624 41630 12913001 10.1074/jbc.M305289200
50. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. C Voisset N Callens E Blanchard A Op De Beeck J Dubuisson N Vu-Dac, J Biol Chem 2005 280 7793 7799 15632171 10.1074/jbc.M411600200
51. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. B Bartosch G Verney M Dreux P Donot Y Morice F Penin JM Pawlotsky D Lavillette FL Cosset, J Virol 2005 79 8217 8229 15956567 10.1128/JVI.79.13.8217-8229.2005
52. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. P Maillard T Huby U Andreo M Moreau J Chapman A Budkowska, FASEB J 2006 20 735 737 16476701
53. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. MB Zeisel G Koutsoudakis EK Schnober A Haberstroh HE Blum FL Cosset T Wakita D Jaeck M Doffoel C Royer E Soulier E Schvoerer C Schuster F Stoll-Keller R Bartenschlager T Pietschmann H Barth TF Baumert, Hepatology 2007 46 1722 1731 18000990 10.1002/hep.21994
54. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Grove T Huby Z Stamataki T Vanwolleghem P Meuleman M Farquhar A Schwarz M Moreau JS Owen G Leroux-Roels P Balfe JA McKeating, J Virol 2007 81 3162 3169 17215280 10.1128/JVI.02356-06
55. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. SB Kapadia H Barth T Baumert JA McKeating FV Chisari, J Virol 2007 81 374 383 17050612 10.1128/JVI.01134-06
56. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Grove S Nielsen J Zhong MF Bassendine HE Drummer P Balfe JA McKeating, J Virol 2008
57. Effect of cell polarization on hepatitis C virus entry. CJ Mee J Grove HJ Harris K Hu P Balfe JA McKeating, J Virol 2008 82 461 470 17959672 10.1128/JVI.01894-07
58. Protein Kinase A dependent step(s) in Hepatitis C virus entry and infectivity. MJ Farquhar HJ Harris M Diskar S Jones CJ Mee SU Nielsen CL Brimacombe S Molina GL Toms P Maurel J Howl FW Herberg SC van Ijzendoorn P Balfe JA McKeating, J Virol 2008
59. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. HJ Harris MJ Farquhar CJ Mee C Davis GM Reynolds A Jennings K Hu F Yuan H Deng SG Hubscher JH Han P Balfe JA McKeating, J Virol 2008 82 5007 5020 18337570 10.1128/JVI.02286-07
60. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. D Lavillette B Bartosch D Nourrisson G Verney FL Cosset F Penin EI Pecheur, J Biol Chem 2006 281 3909 3917 16356932 10.1074/jbc.M509747200
61. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. DM Tscherne CT Jones MJ Evans BD Lindenbach JA McKeating CM Rice, J Virol 2006 80 1734 1741 16439530 10.1128/JVI.80.4.1734-1741.2006
62. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. G Koutsoudakis A Kaul E Steinmann S Kallis V Lohmann T Pietschmann R Bartenschlager, J Virol 2006 80 5308 5320 16699011 10.1128/JVI.02460-05
63. The pathway of HCV IRES-mediated translation initiation. GA Otto JD Puglisi, Cell 2004 119 369 380 15507208 10.1016/j.cell.2004.09.038
64. Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. D Moradpour R Gosert D Egger F Penin HE Blum K Bienz, Antiviral Res 2003 60 103 109 14638405 10.1016/j.antiviral.2003.08.017
65. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. R Gosert D Egger V Lohmann R Bartenschlager HE Blum K Bienz D Moradpour, J Virol 2003 77 5487 5492 12692249 10.1128/JVI.77.9.5487-5492.2003
66. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. CL Jopling M Yi AM Lancaster SM Lemon P Sarnow, Science 2005 309 1577 1581 16141076 10.1126/science.1113329
67. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. P Gastaminza SB Kapadia FV Chisari, J Virol 2006 80 11074 11081 16956946 10.1128/JVI.01150-06
68. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. SU Nielsen MF Bassendine AD Burt C Martin W Pumeechockchai GL Toms, J Virol 2006 80 2418 2428 16474148 10.1128/JVI.80.5.2418-2428.2006
69. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. W Pumeechockchai D Bevitt K Agarwal T Petropoulou BC Langer B Belohradsky MF Bassendine GL Toms, J Med Virol 2002 68 335 342 12226819 10.1002/jmv.10208
70. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. P Andre F Komurian-Pradel S Deforges M Perret JL Berland M Sodoyer S Pol C Brechot G Paranhos-Baccala V Lotteau, J Virol 2002 76 6919 6928 12072493 10.1128/JVI.76.14.6919-6928.2002
71. Tetraspanins in viral infections: a fundamental role in viral biology? F Martin DM Roth DA Jans CW Pouton LJ Partridge PN Monk GW Moseley, J Virol 2005 79 10839 10851 16103137 10.1128/JVI.79.17.10839-10851.2005
72. Tetraspanin functions and associated microdomains. ME Hemler, Nat Rev Mol Cell Biol 2005 6 801 811 16314869 10.1038/nrm1736
73. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. A Higginbottom ER Quinn CC Kuo M Flint LH Wilson E Bianchi A Nicosia PN Monk JA McKeating S Levy, J Virol 2000 74 3642 3649 10729140 10.1128/JVI.74.8.3642-3649.2000
74. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. A Meola A Sbardellati B Bruni Ercole M Cerretani M Pezzanera A Ceccacci A Vitelli S Levy A Nicosia C Traboni J McKeating E Scarselli, J Virol 2000 74 5933 5938 10846074 10.1128/JVI.74.13. 5933-5938.2000
75. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor. F Masciopinto S Campagnoli S Abrignani Y Uematsu P Pileri, Virus Res 2001 80 1 10 11597743 10.1016/S0168-1702(01)00245-3
76. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. HE Drummer KA Wilson P Poumbourios, J Virol 2002 76 11143 11147 12368358 10.1128/JVI.76.21.11143-11147.2002
77. Structure-function analysis of hepatitis C virus envelope-CD81 binding. R Petracca F Falugi G Galli N Norais D Rosa S Campagnoli V Burgio E Di Stasio B Giardina M Houghton S Abrignani G Grandi, J Virol 2000 74 4824 4830 10775621 10.1128/JVI.74.10.4824-4830.2000
78. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein. TH Heo SM Lee B Bartosch FL Cosset CY Kang, Virus Res 2006 121 58 64 16725222 10.1016/j.virusres.2006.04.002
79. Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection. F Masciopinto G Freer VL Burgio S Levy L Galli-Stampino M Bendinelli M Houghton S Abrignani Y Uematsu, Virology 2002 304 187 196 12504561 10.1006/viro.2002.1631
80. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. SL Acton PE Scherer HF Lodish M Krieger, J Biol Chem 1994 269 21003 21009 7520436
81. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. A Rigotti SL Acton M Krieger, J Biol Chem 1995 270 16221 16224 7541795 10.1074/jbc.270.32.18723
82. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. MA Connelly SM Klein S Azhar NA Abumrad DL Williams, J Biol Chem 1999 274 41 47 9867808 10.1074/jbc.274.1.41
83. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Babitt B Trigatti A Rigotti EJ Smart RG Anderson S Xu M Krieger, J Biol Chem 1997 272 13242 13249 9148942 10.1074/jbc.272.20.13242
84. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. NR Webb PM Connell GA Graf EJ Smart WJ de Villiers FC de Beer DR van der Westhuyzen, J Biol Chem 1998 273 15241 15248 9614139 10.1074/jbc.273.24.15241
85. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. S Acton A Rigotti KT Landschulz S Xu HH Hobbs M Krieger, Science 1996 271 518 520 8560269 10.1126/science.271.5248.518
86. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. KT Landschulz RK Pathak A Rigotti M Krieger HH Hobbs, J Clin Invest 1996 98 984 995 8770871 10.1172/JCI118883
87. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. K Murao V Terpstra SR Green N Kondratenko D Steinberg O Quehenberger, J Biol Chem 1997 272 17551 17557 9211901 10.1074/jbc.272.28.17551
88. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. Y Ji B Jian N Wang Y Sun ML Moya MC Phillips GH Rothblat JB Swaney AR Tall, J Biol Chem 1997 272 20982 20985 9261096 10.1074/jbc.272.34. 20982
89. Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. BL Trigatti A Rigotti A Braun, Biochim Biophys Acta 2000 1529 276 286 11111095
90. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. X Gu B Trigatti S Xu S Acton J Babitt M Krieger, J Biol Chem 1998 273 26338 26348 9756864 10.1074/jbc.273.41.26338
91. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. H Stangl M Hyatt HH Hobbs, J Biol Chem 1999 274 32692 32698 10551825 10.1074/jbc.274.46.32692
92. Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. S Swarnakar RE Temel MA Connelly S Azhar DL Williams, J Biol Chem 1999 274 29733 29739 10514447 10.1074/jbc.274.42.29733
93. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. GA Graf PM Connell DR van der Westhuyzen EJ Smart, J Biol Chem 1999 274 12043 12048 10207027 10.1074/jbc.274.17.12043
94. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. X Gu K Kozarsky M Krieger, J Biol Chem 2000 275 29993 30001 11001950 10.1074/jbc.275.39.29993
95. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. DL Silver N Wang X Xiao AR Tall, J Biol Chem 2001 276 25287 25293 11301333 10.1074/jbc.M101726200
96. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. A Rigotti BL Trigatti M Penman H Rayburn J Herz M Krieger, Proc Natl Acad Sci USA 1997 94 12610 12615 9356497 10.1073/pnas.94.23. 12610
97. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. ML Varban F Rinninger N Wang V Fairchild-Huntress JH Dunmore Q Fang ML Gosselin KL Dixon JD Deeds SL Acton AR Tall D Huszar, Proc Natl Acad Sci USA 1998 95 4619 4624 9539787 10.1073/pnas.95.8.4619
98. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. N Wang T Arai Y Ji F Rinninger AR Tall, J Biol Chem 1998 273 32920 32926 9830042 10.1074/jbc.273.49.32920
99. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. MT Catanese R Graziani T von Hahn M Moreau T Huby G Paonessa C Santini A Luzzago CM Rice R Cortese A Vitelli A Nicosia, J Virol 2007 81 8063 8071 17507483 10.1128/JVI.00193-07
100. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. H Aizaki K Morikawa M Fukasawa H Hara Y Inoue H Tani K Saito M Nishijima K Hanada Y Matsuura MM Lai T Miyamura T Wakita T Suzuki, J Virol 2008 82 5715 5724 18367533 10.1128/JVI.02530-07
101. The claudin gene family: expression in normal and neoplastic tissues. KJ Hewitt R Agarwal PJ Morin, BMC Cancer 2006 6 186 16836752 10.1186/1471-2407-6- 186
102. Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. H Wen DD Watry MC Marcondes HS Fox, Mol Cell Biol 2004 24 8408 8417 15367662 10.1128/MCB.24.19.8408-8417.2004
103. Structure and function of claudins. G Krause L Winkler SL Mueller RF Haseloff J Piontek IE Blasig, Biochim Biophys Acta 2008 1778 631 645 18036336
104. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. M Furuse M Hata K Furuse Y Yoshida A Haratake Y Sugitani T Noda A Kubo S Tsukita, J Cell Biol 2002 156 1099 1111 11889141 10.1083/jcb.200110122
105. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. T Nitta M Hata S Gotoh Y Seo H Sasaki N Hashimoto M Furuse S Tsukita, J Cell Biol 2003 161 653 660 12743111 10.1083/jcb.200302070
106. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. A Gow CM Southwood JS Li M Pariali GP Riordan SE Brodie J Danias JM Bronstein B Kachar RA Lazzarini, Cell 1999 99 649 659 10612400 10.1016/S0092-8674(00)81553-6
107. Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. T Ben-Yosef IA Belyantseva TL Saunders ED Hughes K Kawamoto CM Van Itallie LA Beyer K Halsey DJ Gardner ER Wilcox J Rasmussen JM Anderson DF Dolan A Forge Y Raphael SA Camper TB Friedman, Hum Mol Genet 2003 12 2049 2061 12913076 10.1093/hmg/ddg210
108. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Ikenouchi M Furuse K Furuse H Sasaki S Tsukita S Tsukita, J Cell Biol 2005 171 939 945 16365161 10.1083/jcb.200510043
109. Claudins and epithelial paracellular transport: the end of the beginning. AS Yu, Curr Opin Nephrol Hypertens 2003 12 503 509 12920397 10.1097/00041552-200309000-00004
110. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. M Furuse K Fujita T Hiiragi K Fujimoto S Tsukita, J Cell Biol 1998 141 1539 1550 9647647 10.1083/jcb.141.7. 1539
111. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. MJ Evans T von Hahn DM Tscherne AJ Syder M Panis B Wolk T Hatziioannou JA McKeating PD Bieniasz CM Rice, Nature 2007 446 801 805 17325668 10.1038/nature05654
112. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. A Zheng F Yuan Y Li F Zhu P Hou J Li X Song M Ding H Deng, J Virol 2007 81 12465 12471 17804490 10.1128/JVI.01457-07
113. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. L Meertens C Bertaux L Cukierman E Cormier D Lavillette FL Cosset T Dragic, J Virol 2008 82 3555 3560 18234789 10.1128/JVI.01977-07
114. The low density lipoprotein receptor. Identification of amino acids in cytoplasmic domain required for rapid endocytosis. CG Davis IR van Driel DW Russell MS Brown JL Goldstein, J Biol Chem 1987 262 4075 4082 3104336
115. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. MA Lehrman JL Goldstein MS Brown DW Russell WJ Schneider, Cell 1985 41 735 743 3924410 10.1016/S0092-8674(85)80054-4
116. The LDL receptor: how acid pulls the trigger. N Beglova SC Blacklow, Trends Biochem Sci 2005 30 309 317 15950875 10.1016/j.tibs.2005.03.007
117. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. DW Russell MS Brown JL Goldstein, J Biol Chem 1989 264 21682 21688 2600087
118. Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3- methylglutaryl coenzyme A reductase activity. MS Brown JL Goldstein, Proc Natl Acad Sci USA 1974 71 788 792 4362634 10.1073/pnas.71.3.788
119. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. TL Innerarity RW Mahley, Biochemistry 1978 17 1440 1447 206278 10.1021/bi00601a013
120. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. TL Innerarity RE Pitas RW Mahley, J Biol Chem 1979 254 4186 4190 220235
121. A receptor-mediated pathway for cholesterol homeostasis. MS Brown JL Goldstein, Science 1986 232 34 47 3513311 10.1126/science.3513311
122. Functions of cell surface heparan sulfate proteoglycans. M Bernfield M Gotte PW Park O Reizes ML Fitzgerald J Lincecum M Zako, Annu Rev Biochem 1999 68 729 777 10872465 10.1146/annurev.biochem.68.1.729
123. Molecular diversity of heparan sulfate. JD Esko U Lindahl, J Clin Invest 2001 108 169 173 11457867
124. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. A Ploss MJ Evans VA Gaysinskaya M Panis H You YP de Jong CM Rice, Nature 2009 457 882 886 19182773 10.1038/nature07684
125. Hepatitis C virus receptor expression in normal and diseased liver tissue. GM Reynolds HJ Harris A Jennings K Hu J Grove PF Lalor DH Adams P Balfe SG Hubscher JA McKeating, Hepatology 2008 47 418 427 18085708 10.1002/hep.22028